Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,058 | 386 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,143 | 40 | $0 (2024) |
| ABBVIE INC. | $865.89 | 59 | $0 (2024) |
| Novo Nordisk Inc | $474.63 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $455.83 | 32 | $0 (2024) |
| Amgen Inc. | $443.52 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $410.02 | 25 | $0 (2024) |
| Lilly USA, LLC | $398.69 | 32 | $0 (2024) |
| PFIZER INC. | $351.92 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $332.86 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $228.23 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,451 | 83 | ABBVIE INC. ($294.22) |
| 2023 | $2,052 | 101 | Amgen Inc. ($231.11) |
| 2022 | $1,311 | 85 | AstraZeneca Pharmaceuticals LP ($253.40) |
| 2021 | $2,244 | 117 | AstraZeneca Pharmaceuticals LP ($620.33) |
All Payment Transactions
386 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Biological | ||||||
| 10/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $81.46 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Gastroenterology | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Biological | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Diabetes Care | ||||||
| 08/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Respiratory | ||||||
About William Ward, RN
William Ward, RN is a Medical-Surgical healthcare provider based in Opelika, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2019. The National Provider Identifier (NPI) number assigned to this provider is 1376106922.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, William Ward, RN has received a total of $7,058 in payments from pharmaceutical and medical device companies, with $1,451 received in 2024. These payments were reported across 386 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,058).
Practice Information
- Specialty Medical-Surgical
- Other Specialties Adult Health
- Location Opelika, AL
- Active Since 04/18/2019
- Last Updated 09/21/2020
- Taxonomy Code 163WM0705X
- Entity Type Individual
- NPI Number 1376106922
Products in Payments
- VRAYLAR (Drug) $674.82
- FARXIGA (Drug) $595.69
- XARELTO (Drug) $455.83
- ELIQUIS (Drug) $329.65
- Ozempic (Drug) $254.84
- Kerendia (Drug) $228.23
- Otezla (Drug) $186.04
- Azstarys (Drug) $182.53
- AIRSUPRA (Drug) $175.76
- REXULTI (Drug) $171.31
- GVOKE HYPOPEN (Drug) $162.21
- MYRBETRIQ (Drug) $153.54
- Korlym (Drug) $141.37
- Repatha (Biological) $140.33
- Veozah (Drug) $131.41
- XIFAXAN (Drug) $127.10
- Myrbetriq (Drug) $125.07
- Aimovig (Biological) $117.15
- JARDIANCE (Drug) $115.35
- TRELEGY ELLIPTA (Drug) $112.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.